Philip Morris International Inc. to Redeem 2.625% Notes Due 2022
December 13 2021 - 6:15AM
Business Wire
Regulatory News:
Philip Morris International Inc. (NYSE: PM) (“PMI”) today
announced that it will redeem all of its outstanding 2.625% Notes
due February 18, 2022 (the “Notes”) on January 18, 2022 (the
“Redemption Date”). The Notes are listed on the New York Stock
Exchange under the symbol “PM22A” and have been assigned CUSIP No.
718172 BZ1 and ISIN No. US718172BZ15. As of December 13, 2021,
$500,000,000 aggregate principal amount of the Notes were
outstanding. On the Redemption Date, PMI will pay to the registered
holders of the Notes a redemption price equal to 100% of the
principal amount of the Notes, plus accrued and unpaid interest, if
any, thereon to, but excluding, the Redemption Date.
This press release does not constitute a notice of redemption of
the Notes. Holders of the Notes should refer to the notice of
redemption delivered to the registered holders of the Notes by HSBC
Bank USA, National Association, the trustee with respect to the
Notes.
Philip Morris International: Delivering a Smoke-Free
Future
Philip Morris International (PMI) is leading a transformation in
the tobacco industry to create a smoke-free future and ultimately
replace cigarettes with smoke-free products to the benefit of
adults who would otherwise continue to smoke, society, the company,
its shareholders and other stakeholders. PMI is a leading
international tobacco company engaged in the manufacture and sale
of cigarettes, as well as smoke-free products, associated
electronic devices and accessories, and other nicotine-containing
products in markets outside the U.S. In addition, versions of PMI's
IQOS Platform 1 device and consumables have received marketing
authorizations from the U.S. Food and Drug Administration (FDA)
under the premarket tobacco product application (PMTA) pathway; the
FDA has also authorized the marketing of a version of IQOS and its
consumables as a Modified Risk Tobacco Product (MRTP), finding that
an exposure modification order for these products is appropriate to
promote the public health. PMI is building a future on a new
category of smoke-free products that, while not risk-free, are a
much better choice than continuing to smoke. Through
multidisciplinary capabilities in product development,
state-of-the-art facilities and scientific substantiation, PMI aims
to ensure that its smoke-free products meet adult consumer
preferences and rigorous regulatory requirements. PMI's smoke-free
product portfolio includes heat-not-burn products,
nicotine-containing vapor products and oral nicotine products. As
of September 30, 2021, PMI's smoke-free products are available for
sale in 70 markets in key cities or nationwide, and PMI estimates
that approximately 14.9 million adults around the world have
already switched to IQOS and stopped smoking. For more information,
please visit www.pmi.com and www.pmiscience.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211213005373/en/
Philip Morris International Investor Relations: New York:
+1 (917) 663 2233 Lausanne: +41 (0)58 242 4666 Email:
InvestorRelations@pmi.com
Media: Lausanne: +41 (0)58 242 4500 Email:
David.Fraser@pmi.com
Philip Morris (NYSE:PM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Philip Morris (NYSE:PM)
Historical Stock Chart
From Sep 2023 to Sep 2024